Commodore Capital LP has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $1.57 Billion distributed in 37 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Merus N.V. with a value of $332M, Nuvalent, Inc. with a value of $121M, Xenon Pharmaceuticals Inc. with a value of $108M, Cogent Biosciences, Inc. with a value of $104M, and Agios Pharmaceuticals, Inc. with a value of $93.9M.
Examining the 13F form we can see an increase of $494M in the current position value, from $1.07B to 1.57B.
Commodore Capital LP is based out at New York, NY
Below you can find more details about Commodore Capital LP portfolio as well as his latest detailed transactions.
